Profit and Loss Results Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is -24.14% vs -0.17% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is -47.57% vs -4.34% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is -75.11% vs 11.56% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is -58.34% vs -8.65% in Mar 2024
Compare Profit and Loss Results of Saakshi Medtech
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
107.00
579.00
-472.00
-81.52%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
15.00
0.00
15.00
0%
Net Sales
92.00
579.00
-487.00
-84.11%
Expenditure (Ex Depriciation)
Stock Adjustments
-1.00
0.00
-1.00
0%
Raw Materials Consumed
58.00
442.00
-384.00
-86.88%
Power & Fuel Cost
0.00
2.00
-2.00
-100.00%
Employee Cost
15.00
28.00
-13.00
-46.43%
Operating Expenses
0.00
19.00
-19.00
-100.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
8.00
-8.00
-100.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
2.00
-2.00
-100.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
82.00
511.00
-429.00
-83.95%
Operating Profit (PBDIT) excl Other Income
10.00
68.00
-58.00
-85.29%
Other Income
0.00
7.00
-7.00
-100.00%
Operating Profit (PBDIT)
10.00
75.00
-65.00
-86.67%
Interest
0.00
11.00
-11.00
-100.00%
Profit before Depriciation and Tax
10.00
64.00
-54.00
-84.38%
Depreciation
3.00
5.00
-2.00
-40.00%
Profit Before Taxation & Exceptional Items
6.00
58.00
-52.00
-89.66%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
6.00
58.00
-52.00
-89.66%
Provision for Tax
1.00
14.00
-13.00
-92.86%
Profit After Tax
4.00
43.00
-39.00
-90.70%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
40.00
141.00
-101.00
-71.63%
Profit Available for appropriations
45.00
184.00
-139.00
-75.54%
Appropriations
45.00
184.00
-139.00
-75.54%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
2.67
17.46
-14.79
-84.71%
Profit And Loss - Net Sales
Net Sales 92.43 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -24.14% vs -0.17% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 10.31 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -47.57% vs -4.34% in Mar 2024
Profit And Loss - Interest
Interest 0.41 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -75.11% vs 11.56% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax 4.71 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -58.34% vs -8.65% in Mar 2024
Footer loading
